MS treatments: life-changing, but hard to access

More than 100,000 people in the UK have multiple sclerosis (MS), the most common cause of serious physical disability in working age adults, according to the MS guidelines set out by the National Institute for Health and Care Excellence.

Although the condition is regarded as relatively rare and public awareness of it is low, recent innovations in treating and assessing MS are creating a fresh focus on the disease. Research suggests, for example, that MRI scans – already used in diagnosis – may be useful in predicting how MS will progress. In addition, a new drug therapy just approved in the US offers help for symptoms in the most chronic form of the condition. But, given that the drug has yet to be licensed in Europe, can the UK keep up with the latest innovations in the treatment of MS?

This was the backdrop to a recent roundtable discussion, supported by biotech company Sanofi Genzyme. Are the tools for assessing MS fit for purpose? How can early diagnosis and treatment be sped up? What matters to patients? These were among the questions explored by a panel of experts.

What is MS ?

MS is a lifelong neurological condition that affects the central nervous system and involves damage to the coating around the nerve fibres. Symptoms, varying in severity from mild or remitting to debilitating, include difficulties with walking, balance, vision and speech. In its most chronic form, MS can cause blindness and severe disabilities.

While there is no known cure, the past 20 years has seen a shift from no available treatments to the creation of drug modifying therapies (DMTs) to help control symptoms in some types of the condition. Dr Klaus Schmierer, reader in clinical neurology at Queen Mary University of London and consultant neurologist at Barts Health NHS Trust, said: “MS treatment has really taken off and been revolutionised. We need to pick up that pace.”

Read More:  https://www.theguardian.com/healthcare-network/2017/jul/19/ms-treatments-life-changing-but-hard-to-access

Researchers Now Focusing on Diet as a Major MS Treatment
Multiple sclerosis: Antioxidant may slow disease progression
MS treatments: life-changing, but hard to access
A woman with multiple sclerosis claims a local day service 'opened up her life'
Multiple Sclerosis May Affect Ability to Read Social Cues
Multiple Sclerosis Treatment Holds Promise for Friedreich’s Ataxia Patients, Studies Show
Stem Cell Therapy Offers Hope for Multiple Sclerosis Remission
Share This

Be the first to comment

Leave a Reply

Your email address will not be published.


*